Press release
Blood-Brain Barrier Technologies Market - Key Factors Driving the Industry at Rapidly
Blood-brain barrier is the lining of endothelial cells covering the capillaries of the brain. Some of the functions of these blood-brain barriers are as follows:Protecting brain health by preventing pathogens (most common infectious bacteria and viruses and other pathogens) from entering the brain
Excluding and metabolizing neurotoxic compounds (drugs, antibodies and plasma proteins) and neurotransmitters from brain and blood
Safeguarding neurons’ ion balances.
Request a Free PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1019
Some of the major approaches in solving the blood-brain barrier (BBB) problems are lipidation, craniotomy-based drug delivery, BBB disruption, and cationic import peptides. On the basis of application, the global blood-brain barrier technologies market has been segmented into major diseases such as Parkinson’s disease, meningitis, Alzheimer’s disease, multiple sclerosis and encephalitis.
Rising global prevalence of Parkinson’s disease, meningitis, brain abscess, epilepsy, multiple sclerosis, encephalitis, Alzheimer’s disease and rapidly aging world’s population are some of the major drivers for the blood-brain barrier technologies market. According to the European Parkinson’s Disease Association, globally over 6.3 million people are living with Parkinson’s. Parkinson’s disease usually occurs at age of over 60 years. Sources from Parkinson’s Disease Foundation reveals that over 60,000 Americans are diagnosed with Parkinson’s Disease every year. Statistics released by the U.S. Alzheimer's Association indicate that Alzheimer's disease affects more than 5 million people at a time, leading to 500,000 deaths in a year. On account of such high prevalence of blood-brain barrier related diseases, the global market for blood-brain barrier technologies market has been anticipated grow substantially during the forecast period from 2014 to 2020. Blood-brain barriers create CNS drug delivery problems and therefore, manufacturers are making rigorous investments in research and development to invent new drugs and drug delivery systems to amend CNS drug delivery problems. This holds the potential to open up new avenues for the market in terms of future growth opportunities. As most brain related diseases are more likely to affect elderly population, worldwide increasing elderly population is likely to play a key role in driving the market growth for blood-brain barrier technologies.
In terms of geography, the global blood-brain barrier technologies market has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). The North American BBB technologies market held the majority of the market share in 2013; however its market share is expected to reduce significantly through 2020 owing to the rapid economic developments in the Asian-Pacific region and some European Eastern countries. In Asia-Pacific, India and China have been anticipated to witness rapid growth owing to continuously improving economy and healthcare infrastructure. The European BBB technologies market will exhibit relatively moderate CAGR from 2014 to 2020 and will maintain its second position in terms of market share throughout the forecast period. Asia-Pacific is expected to show fastest growth during the forecast period from 2014 to 2020. In Rest of the World region, Middle East, Africa and Latin America are the major markets that are expected to show substantial growth during the forecast period.
Read More: http://www.transparencymarketresearch.com/blood-brain-barrier-technologies.html
Some of the key players of the blood-brain barrier technologies market include Allon Therapeutics, Inc., AngioChem Inc., Genzyme, CeNeRx BioPharma, Inc, Bioasis Technologies Inc., Ablynx NV, Capsulution Pharma AG, International Brain Barriers Society (IBBS), Cephalon Inc, Cognition Pharmaceuticals LLC, Cytos Biotechnology AG, Dainippon Sumitomo Pharma (DSP) Co, Ltd. Bristol-Myers Squibb, Cellial Technologies, Envivo Pharmaceuticals, Inc., InSightec, Ltd., H Lundbeck A/S, Adenios, Inc., ArmaGen Technologies, Inc., Janssen Pharmaceutica NV, BrainCells Inc, In Cerebro, Diamedica Inc., Geron Corporation, Fabre-Kramer Pharmaceuticals, Inc., Eli Lilly and Company, and Cypress Biosciences Inc.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Blood-Brain Barrier Technologies Market - Key Factors Driving the Industry at Rapidly here
News-ID: 353710 • Views: …
More Releases for Parkinson’s
Sales of Parkinson’s Disease Therapeutics Market are Predicted to Rise at …
The global Parkinson’s Disease Therapeutics market is estimated to attain a valuation of US$ 5.24 Bn by the end of 2025, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 10.9% during the forecast period, 2017-2025.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders…
Parkinson’s Disease Therapeutic Market to See Booming Growth 2023-2028 | …
The premium market research firm Coherent Market Insights has published a new market study titled "Parkinson’s Disease Therapeutic Market" Share, Size, Trends, Industry Analysis Report 2022 - 2028." The report offers new perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace.
Parkinson's disease is a movement disorder caused by a neurological condition. Tremor, slowness of movement, tight muscles, an unsteady walk, balance, and coordination issues are all common symptoms.…
Regenerative Medicine & Stem Cells - What’s hot, what’s not, what†…
The competitive landscape of the global regenerative medicine market includes players such as CONMED Corporation, Anika Therapeutics Inc., Arthrex, Inc., Baxter International Inc., Smith & Nephew PLC, DePuy Synthes Inc., Stryker Corporation, Medtronic Inc., and Zimmer Holdings Inc. Though North America and Europe were the largest markets for regenerative medicines, the market players are increasingly shifting their focus on the emerging economies across Asia Pacific such as India, South Korea,…
S+S Metal Detectors for Turkish Coffee From Egypt
Al-Yemeni Cafe, a Cairo based Egyptian company, is a leading producer of ground Turkish coffee. Operating from its own 10,000 square metre factory since 1940, Al-Yemeni Cafe employs the latest state-of-the-art machinery to improve product quality and ensure customer satisfaction. The plant complies with all IFS, ISO 9001 and HACCP standards and holds many quality accreditation from external organisations.
It was particularly important for this application to select metal…
MOODY'S RAISES MOL'S RATINGS TO A3
TOKYO - Mitsui O.S.K. Lines, Ltd. (MOL, President: Akimitsu Ashida) today announced that Moody\'s upgraded the company\'s senior unsecured and issuer ratings from Baa1 to A3.
Moody\'s cited the following points as its main reasons for the upgrade:
1.MOL has greatly reinforced profitability by increasing the efficiency of its ocean shipping business, in order to cope with unsteady freight rates, bunker prices, and foreign exchange rates in recent years. The company…
New addition to the S+S magnet family
At the K 2007 plastics trade fair, hall 10, stand E60, S+S Separation and Sorting Technology GmbH will launch a new member of the magnet family, the SAFEMAG. The SAFEMAG system has been developed in close cooperation with customers from the plastics industry. The requirement is for an especially narrow but sturdy design that takes into consideration the limited available space in the direct vicinity of processing machines. With a…
